About UsA clinical-stage biotechnology company focused on dermatology, wound care, and infectious disease.Read More News Releases Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum September 10, 2026 Read More Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D., as Chief Scientific Officer September 9, 2026 Read More Turn Therapeutics Announces New Peer-Reviewed Research Showing GX-03 Selectively Reduces Key Drivers of Skin Inflammation and Itch August 20, 2026 Read More All News Releases
Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum September 10, 2026 Read More
Turn Therapeutics Appoints Former CDC Director Robert R. Redfield, M.D., as Chief Scientific Officer September 9, 2026 Read More
Turn Therapeutics Announces New Peer-Reviewed Research Showing GX-03 Selectively Reduces Key Drivers of Skin Inflammation and Itch August 20, 2026 Read More
